Search research articles
Contact Us
Filters
Showing results (31-40 of 141) with videos related to
Page
of 15
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice
|
September 11, 2018
How Important Is Adherence to Inhaled Medications Before Starting a Biologic Therapy for Asthma?
Jonathan Corren, Reynold A Panettieri
The Journal of Allergy and Clinical Immunology
|
January 8, 2005
Nasal response to natural cat allergen exposure is significantly greater in patients with rhinitis and asthma than in patients with rhinitis alone
Jonathan Corren, Holly Fish, Jeanette Gumarange
Allergy and Asthma Proceedings
|
December 13, 2002
Efficacy of once-daily desloratadine/pseudoephedrine for relief of nasal congestion
Eric Schenkel, Jonathan Corren, John J Murray
Current Medical Research and Opinion
|
April 8, 2010
Use of mometasone furoate administered via a dry powder inhaler in the treatment of asthma
Michelle Zeidler, Jonathan Corren, Donald P Tashkin
The Journal of Allergy and Clinical Immunology
|
January 18, 2003
Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma
Jonathan Corren, Thomas Casale, Yamo Deniz, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 1, 2020
Variability in Blood Eosinophil Counts in Patients with Eosinophilic Asthma
Jonathan Corren, Evelyn Du, Ananda Gubbi, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 27, 2021
Controversies in Allergy: Choosing a Biologic for Patients with Severe Asthma
Ian D Pavord, Nicola A Hanania, Jonathan Corren
BMC Pediatrics
|
July 15, 2009
Long-term safety of mometasone furoate administered via a dry powder inhaler in children: Results of an open-label study comparing mometasone furoate with beclomethasone dipropionate in children with persistent asthma
Michael Noonan, Jeffrey Leflein, Jonathan Corren, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
October 4, 2007
Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily
William Lumry, Bruce Prenner, Jonathan Corren, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
January 10, 2022
Bronchodilator Responsiveness: An Underappreciated Biomarker for Asthma Exacerbations
William W Busse, Reynold A Panettieri, Jonathan Corren
Page
of 15
Search research articles
Search
Showing results (31-40 of 141) with videos related to
Sort By:
Page
of 15
The Journal of Allergy and Clinical Immunology. in Practice
|
September 11, 2018
How Important Is Adherence to Inhaled Medications Before Starting a Biologic Therapy for Asthma?
Jonathan Corren, Reynold A Panettieri
The Journal of Allergy and Clinical Immunology
|
January 8, 2005
Nasal response to natural cat allergen exposure is significantly greater in patients with rhinitis and asthma than in patients with rhinitis alone
Jonathan Corren, Holly Fish, Jeanette Gumarange
Allergy and Asthma Proceedings
|
December 13, 2002
Efficacy of once-daily desloratadine/pseudoephedrine for relief of nasal congestion
Eric Schenkel, Jonathan Corren, John J Murray
Current Medical Research and Opinion
|
April 8, 2010
Use of mometasone furoate administered via a dry powder inhaler in the treatment of asthma
Michelle Zeidler, Jonathan Corren, Donald P Tashkin
The Journal of Allergy and Clinical Immunology
|
January 18, 2003
Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma
Jonathan Corren, Thomas Casale, Yamo Deniz, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 1, 2020
Variability in Blood Eosinophil Counts in Patients with Eosinophilic Asthma
Jonathan Corren, Evelyn Du, Ananda Gubbi, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 27, 2021
Controversies in Allergy: Choosing a Biologic for Patients with Severe Asthma
Ian D Pavord, Nicola A Hanania, Jonathan Corren
BMC Pediatrics
|
July 15, 2009
Long-term safety of mometasone furoate administered via a dry powder inhaler in children: Results of an open-label study comparing mometasone furoate with beclomethasone dipropionate in children with persistent asthma
Michael Noonan, Jeffrey Leflein, Jonathan Corren, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
October 4, 2007
Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily
William Lumry, Bruce Prenner, Jonathan Corren, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
January 10, 2022
Bronchodilator Responsiveness: An Underappreciated Biomarker for Asthma Exacerbations
William W Busse, Reynold A Panettieri, Jonathan Corren
Page
of 15